RaQualia Pharma Inc.
TSE:4579.T
Overview | Financials
Company Name | RaQualia Pharma Inc. |
Symbol | 4579.T |
Currency | JPY |
Price | 482 |
Market Cap | 10,429,862,558 |
Dividend Yield | 0% |
52-week-range | 450 - 943 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Hirobumi Takeuchi |
Website | https://www.raqualia.co.jp |
An error occurred while fetching data.
About RaQualia Pharma Inc.
RaQualia Pharma Inc. engages in the research and development of pharmaceutical compounds worldwide. Its human products portfolio includes tegoprazan for gastroesophageal reflux disease, which is in phase 1 clinical trial in the United States; and grapiprant for pain management, which is in phase II clinical trial in the United States
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD